Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Aquestive Therapeutics, Inc. (AQST)
since 2018 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Aquestive Therapeutics, Inc..
Table 2 shows the detailed insider transactions.
This company's CIK number is 1398733.
Total stock buying since 2018: $3,132,529.
Total stock sales since 2018: $1,898,373.
Total stock option exercises since 2018: $0.
Table 3. Detailed insider trading at Aquestive Therapeutics, Inc. (AQST)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2024-03-15 | Schobel Alexander Mark (Chief Innovation/Tech Officer) | Sale | 50,000 | 6.00 | 300,000 |
| 2024-03-08 | Schobel Alexander Mark (Chief Innovation/Tech Officer) | Sale | 25,000 | 5.19 | 129,675 |
| 2022-06-14 | Boyd Peter E. (SVP-Bus. Process & Info. Tech.) | Buy | 5,000 | .81 | 4,050 |
| 2022-06-08 | Braender Lori J (General Counsel) | Buy | 13,761 | .96 | 13,210 |
| 2022-06-08 | Barber Daniel (Chief Executive Officer) | Buy | 91,743 | .96 | 88,073 |
| 2022-06-08 | Boyd Peter E. (SVP-Bus. Process & Info. Tech.) | Buy | 2,293 | .96 | 2,201 |
| 2022-06-08 | Schobel Alexander Mark (Chief Innovation/Tech Officer) | Buy | 45,871 | .96 | 44,036 |
| 2021-02-10 | Schobel Alexander Mark (Chief Innovation/Tech Officer) | Sale | 23,460 | 6.75 | 158,355 |
| 2021-02-09 | Schobel Alexander Mark (Chief Innovation/Tech Officer) | Sale | 11,540 | 6.75 | 77,895 |
| 2021-02-08 | Schobel Alexander Mark (Chief Innovation/Tech Officer) | Sale | 40,792 | 6.50 | 265,148 |
| 2020-08-18 | Maxwell John T. (SVP-Chief Financial Officer) | Sale | 3,000 | 8.00 | 24,000 |
| 2020-06-30 | Schobel Alexander Mark (Chief Innovation/Tech Officer) | Option Ex | 333 | .00 | 0 |
| 2020-06-30 | Kendall Keith J (CEO and President) | Option Ex | 333 | .00 | 0 |
| 2020-06-04 | Kendall Keith J (CEO and President) | Sale | 50,000 | 5.11 | 255,300 |
| 2020-05-31 | Schobel Alexander Mark (Chief Innovation/Tech Officer) | Option Ex | 14,572 | .00 | 0 |
| 2020-05-31 | Kendall Keith J (CEO and President) | Option Ex | 14,572 | .00 | 0 |
| 2020-05-08 | Schobel Alexander Mark (Chief Innovation/Tech Officer) | Sale | 40,000 | 5.00 | 200,000 |
| 2020-04-29 | Schobel Alexander Mark (Chief Innovation/Tech Officer) | Sale | 40,000 | 4.50 | 180,000 |
| 2020-04-27 | Schobel Alexander Mark (Chief Innovation/Tech Officer) | Sale | 40,000 | 4.00 | 160,000 |
| 2020-04-14 | Schobel Alexander Mark (Chief Innovation/Tech Officer) | Sale | 40,000 | 3.70 | 148,000 |
| 2020-03-31 | Schobel Alexander Mark (Chief Innovation/Tech Officer) | Option Ex | 329 | .00 | 0 |
| 2020-03-31 | Kendall Keith J (CEO and President) | Option Ex | 329 | .00 | 0 |
| 2020-03-16 | Braender Lori J (SVP, General Counsel) | Buy | 14,000 | 1.54 | 21,630 |
| 2020-03-16 | Boyd Peter E. (SVP-Bus. Process & Info. Tech.) | Buy | 2,000 | 1.50 | 3,000 |
| 2020-02-29 | Schobel Alexander Mark (Chief Innovation/Tech Officer) | Option Ex | 14,572 | .00 | 0 |
| 2020-02-29 | Kendall Keith J (CEO and President) | Option Ex | 14,572 | .00 | 0 |
| 2019-12-31 | Schobel Alexander Mark (Chief Innovation/Tech Officer) | Option Ex | 329 | .00 | 0 |
| 2019-12-31 | Kendall Keith J (CEO and President) | Option Ex | 329 | .00 | 0 |
| 2019-11-30 | Schobel Alexander Mark (Chief Innovation/Tech Officer) | Option Ex | 14,572 | .00 | 0 |
| 2019-11-30 | Kendall Keith J (CEO and President) | Option Ex | 14,572 | .00 | 0 |
| 2019-09-30 | Schobel Alexander Mark (Chief Innovation/Tech Officer) | Option Ex | 329 | .00 | 0 |
| 2019-09-30 | Kendall Keith J (CEO and President) | Option Ex | 329 | .00 | 0 |
| 2019-08-31 | Schobel Alexander Mark (Chief Innovation/Tech Officer) | Option Ex | 14,572 | .00 | 0 |
| 2019-08-31 | Kendall Keith J (CEO and President) | Option Ex | 14,572 | .00 | 0 |
| 2019-08-27 | Barber Daniel (SVP-Chief Operating Officer) | Buy | 2,000 | 3.99 | 7,980 |
| 2019-08-21 | Scibetta James S | Buy | 900 | 3.81 | 3,429 |
| 2019-08-20 | Scibetta James S | Buy | 11,310 | 3.80 | 43,000 |
| 2019-08-19 | Scibetta James S | Buy | 10,761 | 3.77 | 40,547 |
| 2019-08-14 | Kendall Keith J (CEO and President) | Buy | 2,000 | 3.67 | 7,346 |
| 2019-08-13 | Kendall Keith J (CEO and President) | Buy | 1,000 | 4.04 | 4,045 |
| 2019-08-12 | Boyd Peter E. (SVP-Bus. Process & Info. Tech.) | Buy | 600 | 3.81 | 2,286 |
| 2019-08-09 | Braender Lori J (SVP, General Counsel) | Buy | 10,000 | 4.08 | 40,750 |
| 2019-08-09 | Wood Theresa (SVP-HR and Org. Development) | Buy | 1,000 | 3.99 | 3,990 |
| 2019-08-09 | Kendall Keith J (CEO and President) | Buy | 5,000 | 3.92 | 19,600 |
| 2019-06-30 | Schobel Alexander Mark (Chief Innovation/Tech Officer) | Option Ex | 329 | .00 | 0 |
| 2019-06-30 | Kendall Keith J (CEO and President) | Option Ex | 329 | .00 | 0 |
| 2019-05-31 | Schobel Alexander Mark (Chief Innovation/Tech Officer) | Option Ex | 14,572 | .00 | 0 |
| 2019-05-31 | Kendall Keith J (CEO and President) | Option Ex | 14,572 | .00 | 0 |
| 2019-03-31 | Schobel Alexander Mark (Chief Innovation/Tech Officer) | Option Ex | 329 | .00 | 0 |
| 2019-03-31 | Kendall Keith J (CEO and President) | Option Ex | 329 | .00 | 0 |
| 2019-02-28 | Schobel Alexander Mark (Chief Innovation/Tech Officer) | Option Ex | 14,572 | .00 | 0 |
| 2019-02-28 | Kendall Keith J (CEO and President) | Option Ex | 14,572 | .00 | 0 |
| 2018-12-31 | Schobel Alexander Mark (Chief Innovation/Tech Officer) | Option Ex | 329 | .00 | 0 |
| 2018-12-31 | Kendall Keith J (CEO and President) | Option Ex | 329 | .00 | 0 |
| 2018-12-10 | Barber Daniel (SVP-Chief Strategy/Dev Officer) | Buy | 1,000 | 8.00 | 8,000 |
| 2018-12-10 | Schobel Alexander Mark (Chief Innovation/Tech Officer) | Buy | 1,000 | 7.78 | 7,780 |
| 2018-12-06 | Maxwell John T. (SVP-Chief Financial Officer) | Buy | 5,000 | 8.87 | 44,349 |
| 2018-12-06 | Schobel Alexander Mark (Chief Innovation/Tech Officer) | Buy | 2,000 | 8.69 | 17,380 |
| 2018-11-30 | Schobel Alexander Mark (Chief Innovation/Tech Officer) | Option Ex | 14,572 | .00 | 0 |
| 2018-11-30 | Kendall Keith J (CEO and President) | Option Ex | 14,572 | .00 | 0 |
| 2018-11-27 | Braender Lori J (General Counsel) | Buy | 1,000 | 10.57 | 10,570 |
| 2018-11-27 | Kendall Keith J (CEO and President) | Buy | 1,000 | 9.87 | 9,870 |
| 2018-11-26 | Wood Theresa (SVP-HR and Org. Development) | Buy | 500 | 10.34 | 5,170 |
| 2018-11-23 | Kendall Keith J (CEO and President) | Buy | 1,950 | 9.90 | 19,305 |
| 2018-11-21 | Marshall Ken W. (Commercial Leader) | Buy | 1,445 | 10.15 | 14,666 |
| 2018-11-21 | Boyd Peter E. (SVP-Operations/Value Delivery) | Buy | 200 | 9.98 | 1,996 |
| 2018-11-21 | Maxwell John T. (SVP-Chief Financial Officer) | Buy | 10,000 | 9.80 | 98,000 |
| 2018-11-21 | Schobel Alexander Mark (Chief Innovation/Tech Officer) | Buy | 1,000 | 10.25 | 10,250 |
| 2018-11-21 | Kendall Keith J (CEO and President) | Buy | 6,000 | 10.17 | 61,020 |
| 2018-09-30 | Schobel Alexander Mark (Chief Innovation/Tech Officer) | Option Ex | 329 | .00 | 0 |
| 2018-09-30 | Kendall Keith J (CEO and President) | Option Ex | 329 | .00 | 0 |
| 2018-08-31 | Schobel Alexander Mark (Chief Innovation/Tech Officer) | Option Ex | 14,572 | .00 | 0 |
| 2018-08-31 | Kendall Keith J (CEO and President) | Option Ex | 14,572 | .00 | 0 |
| 2018-07-24 | Bratton Capital Inc. (10% Owner) | Buy | 165,000 | 15.00 | 2,475,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
of AQST listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Aquestive Therapeutics, Inc. (symbol AQST,
CIK number 1398733) see
the Securities and Exchange Commission (SEC) website.